Patient enrolment in US early feasibility study of Everdur TAVI device initiated
JenaValve has announced initiation of patient enrolment in its early feasibility study (EFS) of its next-generation JenaValve pericardial transcatheter aortic valve implantation (TAVI) system...
PRECLUDE study of Caisson TMVI system concludes
LivaNova has announced the conclusion of the PRELUDE feasibility study for its Caisson transcatheter mitral valve implantation (TMVI) system. The PRELUDE first-in-human study evaluated...
Safety and efficacy results of REDUCE study published in International Journal of Cardiology
The manuscript “Safety and efficacy of the Reducer: A multicentre clinical registry—REDUCE study” has been published in the International Journal of Cardiology. In this...
Boston Scientific closes acquisition of Claret Medical
Boston Scientific has announced that it has recently closed its acquisition of Claret Medical, which developed and commercialised the Sentinel cerebral embolic protection system—the...
(Visited 11,105 times, 7 visits today)
